Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
X-Bolt Orthopedics is a private orthopedic medical device company developing and commercializing expandable fixation implants for trauma and spine applications, with an initial focus on hip fracture repair in osteoporotic bone. Its lead commercial product, the Pro-X1 Trochanteric Nail, uses an expanding bolt mechanism intended to improve anchorage, reduce cut-out, and lower reoperation risk compared with conventional fixation approaches. The company highlights evidence from large randomized clinical trials in hip fracture fixation and has obtained U.S. FDA 510(k) clearance for multiple systems. Beyond its commercial hip product, X-Bolt is advancing additional pipeline devices in femoral neck plating, retrograde nailing, and spinal pedicle fixation. The business is headquartered in Ireland and is expanding commercialization in the United States through hospital contracting and distributor relationships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on X-Bolt Orthopedics.